These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1027 related articles for article (PubMed ID: 22731672)

  • 1. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.
    Alexander EK; Kennedy GC; Baloch ZW; Cibas ES; Chudova D; Diggans J; Friedman L; Kloos RT; LiVolsi VA; Mandel SJ; Raab SS; Rosai J; Steward DL; Walsh PS; Wilde JI; Zeiger MA; Lanman RB; Haugen BR
    N Engl J Med; 2012 Aug; 367(8):705-15. PubMed ID: 22731672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.
    Labourier E; Shifrin A; Busseniers AE; Lupo MA; Manganelli ML; Andruss B; Wylie D; Beaudenon-Huibregtse S
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2743-50. PubMed ID: 25965083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules.
    McIver B; Castro MR; Morris JC; Bernet V; Smallridge R; Henry M; Kosok L; Reddi H
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4069-77. PubMed ID: 24780044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does addition of BRAF V600E mutation testing modify sensitivity or specificity of the Afirma Gene Expression Classifier in cytologically indeterminate thyroid nodules?
    Kloos RT; Reynolds JD; Walsh PS; Wilde JI; Tom EY; Pagan M; Barbacioru C; Chudova DI; Wong M; Friedman L; LiVolsi VA; Rosai J; Lanman RB; Kennedy GC
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E761-8. PubMed ID: 23476074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Has Afirma gene expression classifier testing refined the indeterminate thyroid category in cytology?
    Yang SE; Sullivan PS; Zhang J; Govind R; Levin MR; Rao JY; Moatamed NA
    Cancer Cytopathol; 2016 Feb; 124(2):100-9. PubMed ID: 26422098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid Nodules.
    Patel KN; Angell TE; Babiarz J; Barth NM; Blevins T; Duh QY; Ghossein RA; Harrell RM; Huang J; Kennedy GC; Kim SY; Kloos RT; LiVolsi VA; Randolph GW; Sadow PM; Shanik MH; Sosa JA; Traweek ST; Walsh PS; Whitney D; Yeh MW; Ladenson PW
    JAMA Surg; 2018 Sep; 153(9):817-824. PubMed ID: 29799911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGA2 gene expression analysis performed on cytologic smears to distinguish benign from malignant thyroid nodules.
    Lappinga PJ; Kip NS; Jin L; Lloyd RV; Henry MR; Zhang J; Nassar A
    Cancer Cytopathol; 2010 Oct; 118(5):287-97. PubMed ID: 20597139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of the Afirma Gene Expression Classifier in Hürthle Cell Thyroid Nodules Differs from Other Indeterminate Thyroid Nodules.
    Brauner E; Holmes BJ; Krane JF; Nishino M; Zurakowski D; Hennessey JV; Faquin WC; Parangi S
    Thyroid; 2015 Jul; 25(7):789-96. PubMed ID: 25962906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical diagnostic gene expression thyroid testing.
    Steward DL; Kloos RT
    Otolaryngol Clin North Am; 2014 Aug; 47(4):573-93. PubMed ID: 25041959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can a gene-expression classifier with high negative predictive value solve the indeterminate thyroid fine-needle aspiration dilemma?
    Faquin WC
    Cancer Cytopathol; 2013 Mar; 121(3):116-9. PubMed ID: 23364882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration.
    Keutgen XM; Filicori F; Crowley MJ; Wang Y; Scognamiglio T; Hoda R; Buitrago D; Cooper D; Zeiger MA; Zarnegar R; Elemento O; Fahey TJ
    Clin Cancer Res; 2012 Apr; 18(7):2032-8. PubMed ID: 22351693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter clinical experience with the Afirma gene expression classifier.
    Alexander EK; Schorr M; Klopper J; Kim C; Sipos J; Nabhan F; Parker C; Steward DL; Mandel SJ; Haugen BR
    J Clin Endocrinol Metab; 2014 Jan; 99(1):119-25. PubMed ID: 24152684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship Between Sonographic Characteristics and Afirma Gene Expression Classifier Results in Thyroid Nodules With Indeterminate Fine-Needle Aspiration Cytopathology.
    Zhu QL; Faquin WC; Samir AE
    AJR Am J Roentgenol; 2015 Oct; 205(4):861-5. PubMed ID: 26397337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.
    Bartolazzi A; Orlandi F; Saggiorato E; Volante M; Arecco F; Rossetto R; Palestini N; Ghigo E; Papotti M; Bussolati G; Martegani MP; Pantellini F; Carpi A; Giovagnoli MR; Monti S; Toscano V; Sciacchitano S; Pennelli GM; Mian C; Pelizzo MR; Rugge M; Troncone G; Palombini L; Chiappetta G; Botti G; Vecchione A; Bellocco R;
    Lancet Oncol; 2008 Jun; 9(6):543-9. PubMed ID: 18495537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of a suspicious afirma test result in thyroid fine-needle aspiration cytology: an institutional experience.
    Lastra RR; Pramick MR; Crammer CJ; LiVolsi VA; Baloch ZW
    Cancer Cytopathol; 2014 Oct; 122(10):737-44. PubMed ID: 25123499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular diagnostic testing and the indeterminate thyroid nodule.
    Yip L
    Curr Opin Oncol; 2014 Jan; 26(1):8-13. PubMed ID: 24225416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular diagnostics for thyroid nodules: the current state of affairs.
    Mon SY; Hodak SP
    Endocrinol Metab Clin North Am; 2014 Jun; 43(2):345-65. PubMed ID: 24891166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study.
    Steward DL; Carty SE; Sippel RS; Yang SP; Sosa JA; Sipos JA; Figge JJ; Mandel S; Haugen BR; Burman KD; Baloch ZW; Lloyd RV; Seethala RR; Gooding WE; Chiosea SI; Gomes-Lima C; Ferris RL; Folek JM; Khawaja RA; Kundra P; Loh KS; Marshall CB; Mayson S; McCoy KL; Nga ME; Ngiam KY; Nikiforova MN; Poehls JL; Ringel MD; Yang H; Yip L; Nikiforov YE
    JAMA Oncol; 2019 Feb; 5(2):204-212. PubMed ID: 30419129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Thyroid Genetic Classifier Correctly Predicts Benign Nodules with Indeterminate Cytology: Two Independent, Multicenter, Prospective Validation Trials.
    Zafereo M; McIver B; Vargas-Salas S; Domínguez JM; Steward DL; Holsinger FC; Kandil E; Williams M; Cruz F; Loyola S; Solar A; Roa JC; León A; Droppelman N; Lobos M; Arias T; Kong CS; Busaidy N; Grubbs EG; Graham P; Stewart J; Tang A; Wang J; Orloff L; Henríquez M; Lagos M; Osorio M; Schachter D; Franco C; Medina F; Wohllk N; Diaz RE; Veliz J; Horvath E; Tala H; Pineda P; Arroyo P; Vasquez F; Traipe E; Marín L; Miranda G; Bruce E; Bracamonte M; Mena N; González HE
    Thyroid; 2020 May; 30(5):704-712. PubMed ID: 31910118
    [No Abstract]   [Full Text] [Related]  

  • 20. Differentiating benign from malignant thyroid nodules using micro ribonucleic acid amplification in residual cells obtained by fine needle aspiration biopsy.
    Mazeh H; Levy Y; Mizrahi I; Appelbaum L; Ilyayev N; Halle D; Freund HR; Nissan A
    J Surg Res; 2013 Apr; 180(2):216-21. PubMed ID: 22626557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.